Skip to results
Modify your search
NARROW
1-7 of 7
Authors: Romain Coriat
Journal Article
Withholding the Introduction of Anti‐Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild‐Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study) Open Access
The Oncologist, Volume 25, Issue 2, February 2020, Pages e266–e275, https://doi.org/10.1634/theoncologist.2019-0328
Published: 02 October 2019
Journal Article
Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey Free
The Oncologist, Volume 24, Issue 12, December 2019, Pages e1351–e1359, https://doi.org/10.1634/theoncologist.2019-0166
Published: 19 July 2019
Journal Article
Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients Free
The Oncologist, Volume 24, Issue 12, December 2019, Pages e1331–e1340, https://doi.org/10.1634/theoncologist.2018-0914
Published: 31 May 2019
Journal Article
In Reply Free
The Oncologist, Volume 22, Issue 3, March 2017, Pages 359–360, https://doi.org/10.1634/theoncologist.2016-0393
Published: 09 March 2017
Journal Article
Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement Free
The Oncologist, Volume 21, Issue 10, October 2016, Pages 1191–1199, https://doi.org/10.1634/theoncologist.2015-0476
Published: 08 July 2016
Journal Article
Variability of Sorafenib Toxicity and Exposure over Time: A Pharmacokinetic/Pharmacodynamic Analysis Free
The Oncologist, Volume 17, Issue 9, September 2012, Pages 1204–1212, https://doi.org/10.1634/theoncologist.2011-0439
Published: 02 July 2012
Journal Article
An Observational Study of Bevacizumab‐Induced Hypertension as a Clinical Biomarker of Antitumor Activity Free
The Oncologist, Volume 16, Issue 9, September 2011, Pages 1325–1332, https://doi.org/10.1634/theoncologist.2010-0002
Published: 01 August 2011
